Patient and practitioner influences on the placebo effect in irritable bowel syndrome

Psychosomatic Medicine

Volumn 71, Issue 7, 2009, Pages 789-797

  Kelley, John M ^a,b   Lembo, Anthony J ^c   Ablon, J Stuart ^b   Villanueva, Joel J ^b   Conboy, Lisa A ^c   Levy, Ray ^b   Marci, Carl D ^b   Kerr, Catherine E ^c   Kirsch, Irving ^d   Jacobson, Eric E ^c   Riess, Helen ^b   Kaptchuk, Ted J ^c  

^a ENDICOTT COLLEGE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF HULL   (United Kingdom)

Author keywords

Acupuncture; Irritable bowel syndrome; Patient practitioner relationship; Personality; Placebo effect

Indexed keywords

PLACEBO;

ACUPUNCTURE; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOCTOR PATIENT RELATION; FEMALE; GENDER; HEALTH CARE; HUMAN; HUMAN RELATION; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PERSONALITY; PHYSICIAN; PLACEBO EFFECT; PRIORITY JOURNAL; PSYCHOMETRY; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL;

EID: 70349678526     PISSN: 00333174     EISSN: 15347796     Source Type: Journal    
DOI: 10.1097/PSY.0b013e3181acee12     Document Type: Article

References (55)

1. Hrobjartsson A, Gotzsche PC. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med 2001;344:1594-1602
2. Kaptchuk TJ, Kelley JM, Conboy LA, Davis RB, Kerr CE, Jacobson EE, Kirsch I, Schyner RN, Nam BH, Nguyen LT, Park M, Rivers AL, McManus C, Kokkoto E, Drossman DA, Goldman P, Lembo AJ. Components of placebo effect: randomized controlled trial in patients with irritable bowel syndrome. BMJ 2008;336:998-1003.
3. Shapiro AK, Shapiro E. The Powerful Placebo: From Ancient Priest to Modern Physician. Baltimore: Johns Hopkins University Press; 1997.
4. Brody H. The Placebo Response. New York: HarperCollins; 2000.
5. Hyland ME, Whalley B, Kirsch I. Consistency of the placebo effect. J Psychosom Res 2008;64:537-541
6. Kaptchuk TJ, Kelley JM, Deykin A, Wayne PM, Lasagna LC, Epstein IO, Kirsch I, Wechsler ME. Do "placebo responders" exist? Contemp Clin Trials 2008;29:587-595
7. Kim D, Wampold BE, Bolt DM. Therapist effects in psychotherapy: a random-effects modeling of the National Institute of Mental Health treatment of depression collaborative research program data. Psychotherapy Research 2006;16:161-172
8. Luborsky L, McLellan AT, Diguer L, Woody G, Seligman DA. The psychotherapist matters: comparison of outcomes across twenty-two therapists and seven patient samples. Clinical Psychology: Science and Practice 1997;4:53-65.
9. Wampold BE, Brown GS. Estimating variability in outcomes attributable to therapists: a naturalistic study of outcomes in managed care. J Consult Clin Psychol 2005;73:914-923
10. Thomas KB. General practice consultations: is there any point in being positive? Br Med J (Clin Res Ed) 1987;294:1200-1202
11. Hall JA, Harrigan JA, Rosenthal R. Nonverbal behavior in clinicianpatient interaction. Appl Prev Psychol 1995;4:21-37.
12. Di Blasi Z, Harkness E, Ernst E, Georgiu A, Kleijnen J. Influence of context effects on health outcomes: a systematic review. Lancet 2001; 357:757-762
13. Stepien KA, Baernstein A. Educating for empathy. A review. J Gen Intern Med 2006;21.
14. Conboy LA, Wasserman RH, Jacobson EE, Davis RB, Legedza ATR, Park M, Rivers AL, Morey EB, Nam BH, Lasagna L, Kirsch I, Lembo AJ, Kaptchuk TJ, Kerr CE. Investigating placebo effects in irritable bowel syndrome: a novel research design. Contemp Clin Trials 2006;27: 123-134
15. Thompson WG, Longstreth G, Drossman D, Heaton K, Irvine E, Muller- Lissner S. Functional bowel disorders and functional abdominal pain. Gut 1999;45(Suppl 2):II43-II47.
16. Streitberger K, Kleinhenz J. Introducing a placebo needle into acupuncture research. Lancet 1998;352:354-365
17. Drossman DA, Toner BB, Whitehead WE, Diamant NE, Dalton CB, Duncan S, Emmott S, Proffitt V, Akman D, Frusciante K, Le T, Meyer K, Bradshaw B, Mikula K, Morris CB, Blackman CJ, Hu Y, Jia H, Li JZ, Koch GG, Bangdiwala SI. Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. Gastroenterology 2003;125:19-31.
18. Keefer L, Blanchard EB. The effects of relaxation response meditation on the symptoms of irritable bowel syndrome: results of a controlled treatment study. Behav Res Ther 2001;39:801-811
19. Bengtsson M, Ulander K, Borgdal EB, Christensson AC, Ohlsson BA. A course of instruction for women with irritable bowel syndrome. Patient Educ Coun 2006;62:118-125
20. Lang EV, Benotsch EG, Fick LJ. Adjunctive non-pharmacological analgesia for invasive medical procedures: a randomised trial. Lancet 2000: 1486-1490
21. Morag E, Lieberman G, Volkan K, Shaffer K, Novelline R, Lang EV. Clinical competence assessment in radiology: introduction of an objective structured clinical examination in the medical school curriculum. Acad Radiol 2001;8:74-81.
22. Moncher FJ, Prinz FJ. Treatment fidelity in outcomes studies. Clin Psychol Rev 1991;11:247-266
23. Francis C, Morris J, Whorwell P. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther 1997;11:395-402.
24. Drossman DA, Morris CB, Hu Y, Toner BB, Diamant N, Whitehead WE, Dalton CB, Leserman J, Patrick DL, Bangdiwala SI. Characterization of health related quality of life (HRQOL) for patients with functional bowel disorder (FBD) and its response to treatment. Am J Gastroenterol 2007; 102:1442-1453
25. Lembo T, Wright RA, Bagby B, Decker C, Gordon S, Jhingran P, Carter E. Alosetron controls bowel urgency and provides global symptom improvement in women with diarrhea-predominant irritable bowel syndrome. Am J Gastroenterol 2001;96:2662-2670
26. Gordon S, Ameen V, Bagby B, Shahan B, Jhingran P, Carter E. Valida- tion of irritable bowel syndrome Global Improvement Scale: an integrated symptom end point for assessing treatment efficacy. Dig Dis Sci 2003;48:1317-1323
27. Mangel AW. Personal view: adequate relief as a primary endpoint in irritable bowel syndrome. Aliment Pharmacol Ther2006;23:879-881
28. Mangel AW, Hahn BA, Heath AT, Northcutt AR, Kong S, Dukes GE, McSorley D. Adequate relief as an endpoint in clinical trials in irritable bowel syndrome. J Int Med Res 1998;26:76-81.
29. Costa PT, McCrae RR. NEO Personality Inventory (NEO PI-R) and NEO Five-Factor Inventory (NEO-FFI): Professional Manual. Odessa, FL: Psychological Assessment Resources; 1992.
30. Jones EE. Therapeutic Action: A Guide to Psychoanalytic Therapy. Northvale, NJ: Jason Aronson; 2000.
31. Ablon JS, Jones EE. How expert clinicians' prototypes of an ideal treatment correlated with outcome in psychodynamic and cognitivebehavioral therapy. Psychother Res 1998;8:71-83.
32. Ablon JS, Jones EE. Validity of controlled clinical trials of psychotherapy: findings from the NIMH Treatment of Depression Collaborative Research Program. Am J Psychiatry 2002;159:775-783
33. Pole N, Ablon JS, O'Connor L. Ideal control mastery technique correlates with change in a single case. Psychotherapy: Theory, Research, Practice, Training 2002;39:88-96.
34. Pole N, Ablon JS, O'Connor L. Using psychodynamic, cognitivebehavioral, and control mastery prototypes to predict change: a new look at an old paradigm for long-term single case research. J Counseling Psychol 2008;55:221-232
35. Ablon JS, Jones EE. Psychotherapy process in the NIMH collaborative study of depression. J Consult Clin Psychol 1999;67:64-75.
36. Wampold BE. The Great Psychotherapy Debate: Models, Methods, and Findings. Mahwah, NJ: Lawrence Erlbaum; 2001.
37. Hubble MA, Duncan BL, Miller SD. The Heart and Soul of Change: What Works in Psychotherapy. Washington, DC: American Psychological Association; 1999.
38. Frank JD. Therapeutic Factors in Psychotherapy. Am J Psychother 1971; 25:350-361
39. Ackerman SJ, Hilsenroth MJ. A review of therapist characteristics and techniques positively impacting the therapeutic alliance. Clin Psychol Rev 2003;23:1-33.
40. Stiles WB, Shapiro DA, Elliott R. "Are All Psychotherapies Equivalent?" Am Psychol 1986;41:165-180
41. Horvath AO, Symonds BD. Relation between working alliance and outcome in psychotherapy: a meta-analysis. J Counseling Psychol 1991; 38:139-149
42. Honaker J, King G, Blackwell M. Amelia II: A Program for Missing Data. Manual. 2006. Available at http://gking.harvard.edu/amelia/docs/ amelia.pdf.
43. Rubin DB. Multiple Imputation for Nonresponse in Surveys. New York: John Wiley & Sons; 1987.
44. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988.
45. Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med 2008;358:252-260
46. Blatt SJ, Sanislow CA, Zuroff DC, Pilkonis PA. Characteristics of effective therapists: further analyses of data from the National Institute of Mental Health treatment of depression collaborative research program. J Consult Clin Psychol 1996;64:1276-1284
47. Najavits LM, Weiss RD. Variations in therapist effectiveness in the treatment of patients with substance use disorders: an empirical review. Addiction 1994;89:679-688
48. Crits-Christoph P, Mintz J. Implications of therapist effects for the design and analysis of comparative studies of psychotherapies. J Consult Clin Psychol 1991;59:20-26
49. Klosterhalfen S, Enck P. Psychobiology of the placebo response. Autonomic Neuroscience 2006;125:94-99
50. Kaptchuk TJ, Shaw J, Kerr CE, Conboy LA, Kelley JM, Csordas TJ, Lembo AJ, Jacobson EE. Maybe I made up the whole thing: placebos and patients' experiences in a randomized controlled trial. Cult Med Psychiatry, In Press.
51. Kaptchuk TJ, Stason WB, Davis RB, Legedza ATR, Schnyer RS, Kerr CE, Stone DA, Nam BH, Kirsch I, Goldman P. Sham device versus inert pill: a randomized controlled trial comparing two placebo treatments for arm pain due to repetitive strain injury. BMJ 2006;332:391-397
52. Kaptchuk TJ, Goldman P, Stone DA, Stason WB. Do medical devices have enhanced placebo effects? J Clin Epidemiol 2000;53:786-792
53. Benedetti F, Mayberg HS, Wager TD, Stohler CS, Zubieta JK. Neurobiological mechanisms of the placebo effect. J Neurosci 2005;25: 10390-10402
54. Pacheco-López G, Engler H, Niemi MB, Schedlowski M. Expectations and associations that heal: immunomodulatory placebo effects and its neurobiology. Brain Behav Immun 2006:430-446
55. Enck P, Benedetti F, Schedlowski M. New insights into the placebo and nocebo responses. Neuron 2008;59:195-206.